Dr. Christopher Bruno, DO
NPI: 1932385408
Total Payments
$62,106
2024 Payments
$2,048
Companies
56
Transactions
700
Medicare Patients
5,447
Medicare Billing
$605,292
Payment Breakdown by Category
Other$46,945 (75.6%)
Food & Beverage$12,086 (19.5%)
Consulting$1,530 (2.5%)
Travel$1,484 (2.4%)
Education$60.86 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $42,355 | 31 | 68.2% |
| Food and Beverage | $12,086 | 644 | 19.5% |
| Compensation for serving as faculty or as a speaker for a medical education program | $4,590 | 3 | 7.4% |
| Consulting Fee | $1,530 | 1 | 2.5% |
| Travel and Lodging | $1,484 | 18 | 2.4% |
| Education | $60.86 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $24,118 | 89 | $0 (2024) |
| Merck Sharp & Dohme LLC | $18,309 | 51 | $0 (2023) |
| Dexcom, Inc. | $11,006 | 31 | $0 (2024) |
| Novo Nordisk Inc | $1,215 | 91 | $0 (2024) |
| Lilly USA, LLC | $1,005 | 69 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $720.88 | 42 | $0 (2024) |
| Amgen Inc. | $675.69 | 44 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $508.43 | 29 | $0 (2024) |
| Medtronic, Inc. | $454.91 | 29 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $439.09 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,048 | 111 | Novo Nordisk Inc ($342.47) |
| 2023 | $1,923 | 110 | Novo Nordisk Inc ($258.29) |
| 2022 | $6,570 | 98 | Dexcom, Inc. ($4,849) |
| 2021 | $14,902 | 82 | AstraZeneca Pharmaceuticals LP ($8,562) |
| 2020 | $10,614 | 46 | AstraZeneca Pharmaceuticals LP ($10,068) |
| 2019 | $11,422 | 89 | Merck Sharp & Dohme Corporation ($5,899) |
| 2018 | $13,286 | 81 | Merck Sharp & Dohme Corporation ($12,319) |
| 2017 | $1,341 | 83 | Dexcom, Inc. ($237.58) |
All Payment Transactions
700 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Bone Health | ||||||
| 12/19/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $3.75 | General |
| Category: Durable Pump | ||||||
| 12/11/2024 | Ascensia Diabetes Care Us Inc. | EVERSENSE 365 SENSOR KIT (RETAIL) (Device) | Food and Beverage | In-kind items and services | $28.96 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.34 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Diabetes Care | ||||||
| 12/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Cardio-renal | ||||||
| 12/03/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Durable Pump | ||||||
| 12/03/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $3.75 | General |
| Category: Durable Pump | ||||||
| 11/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Diabetes | ||||||
| 11/22/2024 | Acella Pharmaceuticals, LLC | NP Thyroid 60 (Drug) | Food and Beverage | In-kind items and services | $29.14 | General |
| Category: Hyperthyroidism | ||||||
| 11/15/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $19.78 | General |
| Category: Endocrinology | ||||||
| 10/31/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: Bone Health | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.49 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Cardio-renal | ||||||
| 10/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $31.03 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Obesity | ||||||
| 10/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: DIABETES | ||||||
| 10/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Cardio-renal | ||||||
| 10/09/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/03/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $5.43 | General |
| Category: Durable Pump | ||||||
| 10/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Cardio-renal | ||||||
| 10/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Diabetes | ||||||
| 09/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,322 | 1,978 | $262,703 | $152,385 |
| 2022 | 12 | 1,372 | 2,036 | $256,426 | $159,040 |
| 2021 | 12 | 1,379 | 2,084 | $263,251 | $161,499 |
| 2020 | 15 | 1,374 | 1,927 | $237,106 | $132,368 |
Total Patients
5,447
Total Services
8,025
Medicare Billing
$605,292
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 605 | 1,025 | $172,230 | $97,671 | 56.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 68 | 69 | $17,526 | $9,896 | 56.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 137 | 148 | $17,621 | $9,371 | 53.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 99 | 99 | $8,405 | $7,114 | 84.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 67 | 153 | $9,027 | $6,392 | 70.8% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 114 | 224 | $12,320 | $6,182 | 50.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 62 | 90 | $8,370 | $5,975 | 71.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $7,689 | $4,002 | 52.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 110 | 110 | $5,580 | $3,526 | 63.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 16 | 16 | $2,560 | $1,566 | 61.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 11 | 11 | $1,375 | $689.13 | 50.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 559 | 972 | $151,632 | $94,297 | 62.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 83 | 86 | $21,844 | $14,234 | 65.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 142 | 151 | $16,157 | $9,690 | 60.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 63 | 63 | $14,679 | $7,713 | 52.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 80 | 128 | $11,904 | $7,643 | 64.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 103 | 103 | $7,725 | $7,053 | 91.3% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 78 | 184 | $10,856 | $6,000 | 55.3% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 99 | 179 | $9,845 | $5,077 | 51.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 114 | 114 | $4,104 | $3,582 | 87.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 23 | 28 | $4,480 | $2,680 | 59.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 16 | 16 | $2,000 | $749.92 | 37.5% |
| 92250 | Photography of the retina | Office | 2022 | 12 | 12 | $1,200 | $320.84 | 26.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 524 | 933 | $145,548 | $91,938 | 63.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 80 | 85 | $21,590 | $13,294 | 61.6% |
About Dr. Christopher Bruno, DO
Dr. Christopher Bruno, DO is a Endocrinology, Diabetes & Metabolism healthcare provider based in Collegeville, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/15/2008. The National Provider Identifier (NPI) number assigned to this provider is 1932385408.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Bruno, DO has received a total of $62,106 in payments from pharmaceutical and medical device companies, with $2,048 received in 2024. These payments were reported across 700 transactions from 56 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($42,355).
As a Medicare-enrolled provider, Bruno has provided services to 5,447 Medicare beneficiaries, totaling 8,025 services with total Medicare billing of $605,292. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Collegeville, PA
- Active Since 01/15/2008
- Last Updated 10/03/2025
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1932385408
Products in Payments
- FARXIGA (Drug) $24,118
- STEGLATRO (Drug) $15,348
- DEXCOM G6 TRANSMITTER (Device) $5,580
- Dexcom G6 Transmitter (Medical Supply) $4,975
- JARDIANCE (Drug) $704.40
- Ozempic (Drug) $466.71
- MOUNJARO (Drug) $465.57
- Kerendia (Drug) $439.09
- TRADJENTA (Drug) $269.91
- Dexcom G5 Mobile CGM System (Device) $237.58
- MINIMED 780G (Device) $225.33
- Prolia (Biological) $220.11
- Repatha (Biological) $214.37
- EVENITY (Biological) $213.28
- Rybelsus (Drug) $197.22
- JANUVIA (Drug) $191.47
- SYNTHROID (Drug) $187.16
- LICART (Drug) $186.90
- SOLIQUA 100/33 (Biological) $181.20
- Tirosint (Drug) $175.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Collegeville
Sumon Agarwala, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $619,305
Endocrinology, Diabetes & Metabolism $619,305
Vishal Datta, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $488,660
Endocrinology, Diabetes & Metabolism $488,660
Dr. Lisa Hamaker, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $780.14
Endocrinology, Diabetes & Metabolism $780.14
Gayle Orczyk, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $21.90
Endocrinology, Diabetes & Metabolism $21.90
Dr. Suzette Osei, M.d, M.D
Endocrinology, Diabetes & Metabolism
Endocrinology, Diabetes & Metabolism